Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
AgeX Therapeutics, Inc. (AGE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 SC 13D/A Juvenescence Ltd reports a 78.6% stake in AGEX THERAPEUTICS, INC.
03/22/2023 SC 13D/A Juvenescence Ltd reports a 78.7% stake in AGEX THERAPEUTICS, INC.
01/27/2023 SC 13D/A Juvenescence Ltd reports a 72.6% stake in AGEX THERAPEUTICS, INC.
12/15/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/25/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/23/2022 SC 13D/A Juvenescence Ltd reports a 72.1% stake in AGEX THERAPEUTICS, INC.
06/24/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/11/2022 SC 13D/A Juvenescence Ltd reports a 68.1% stake in AGEX THERAPEUTICS, INC.
02/22/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/14/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/13/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/18/2021 SC 13D/A Juvenescence Ltd reports a 63% stake in AGEX THERAPEUTICS, INC.
11/02/2021 SC 13D/A Juvenescence Ltd reports a 63% stake in AGEX THERAPEUTICS, INC.
09/14/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/26/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/11/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/17/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/09/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/12/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/19/2020 SC 13D/A Juvenescence Ltd reports a 50% stake in AGEX THERAPEUTICS, INC.
10/07/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/31/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/06/2020 SC 13D/A Juvenescence Ltd has filed a Schedule 13D for AGEX THERAPEUTICS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy